MCKESSON CORPORATION
Entity uei:S1RUKWWRYFL6 · UEI S1RUKWWRYFL6 · parent: MCKESSON CORPORATION
Obligations by fiscal year
Awards (35)
| 36C24026K1002↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | Nov 1, 2025 – Nov 30, 2025 | $1.4B | $1.4B | 0 |
| 36C24026K1008↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 MAY | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | May 1, 2026 – May 30, 2026 | $1.4B | $1.4B | 0 |
| 36C24026K1009↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JUNE | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | Jun 1, 2026 – Jun 30, 2026 | $1.2B | $1.2B | 0 |
| 36C24026K1007↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 APRIL | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | Apr 1, 2026 – Apr 30, 2026 | $1.2B | $1.2B | 0 |
| 36C24026K1001↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | Oct 1, 2025 – Oct 31, 2025 | $1.2B | $1.2B | 0 |
| 36C24025K1012↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 SEPTEMBER | Department of Veterans Affairs Department of Veterans Affairs | FY2025 | Sep 1, 2025 – Sep 30, 2025 | $1.2B | $1.2B | 0 |
| 36C24026K1006↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 MARCH | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | Mar 1, 2026 – Mar 31, 2026 | $1.2B | $1.2B | 0 |
| 36C24025K1010↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 JULY | Department of Veterans Affairs Department of Veterans Affairs | FY2025 | Jul 1, 2025 – Jul 31, 2025 | $1.1B | $1.1B | 0 |
| 36C24026K1003↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | Dec 1, 2025 – Dec 31, 2025 | $1.1B | $1.1B | 0 |
| 36C24026K1004↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | Jan 1, 2026 – Jan 31, 2026 | $1.1B | $1.1B | 0 |
| 36C24025K1011↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 AUGUST | Department of Veterans Affairs Department of Veterans Affairs | FY2025 | Aug 1, 2025 – Aug 30, 2025 | $1.1B | $1.1B | 0 |
| 36C24026K1005↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 FEBRUARY | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | Feb 1, 2026 – Feb 28, 2026 | $1.1B | $1.1B | 0 |
| 36C24025K1001↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 OCTOBER | Department of Veterans Affairs Department of Veterans Affairs | FY2025 | Oct 1, 2024 – Oct 31, 2024 | $1.0B | $1.0B | 0 |
| 36C24025K1007↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 APRIL | Department of Veterans Affairs Department of Veterans Affairs | FY2025 | Apr 1, 2025 – Apr 30, 2025 | $1.0B | $1.0B | 0 |
| 36C24025K1008↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 MAY | Department of Veterans Affairs Department of Veterans Affairs | FY2025 | May 1, 2025 – May 30, 2025 | $1.0B | $1.0B | 0 |
| 36C24025K1009↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 JUNE | Department of Veterans Affairs Department of Veterans Affairs | FY2025 | Jun 1, 2025 – Jun 30, 2025 | $1.0B | $1.0B | 0 |
| 36C24025K1006↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 MARCH | Department of Veterans Affairs Department of Veterans Affairs | FY2025 | Mar 1, 2025 – Mar 31, 2025 | $1000.0M | $1000.0M | 0 |
| 36C24024K1010↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 JULY | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | Jul 1, 2024 – Jul 31, 2024 | $971.8M | $971.8M | 0 |
| 36C24024K1012↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 SEPTEMBER | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | Sep 1, 2024 – Sep 30, 2024 | $953.2M | $953.2M | 0 |
| 36C24024K1011↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 AUGUST | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | Aug 1, 2024 – Aug 31, 2024 | $943.8M | $943.8M | 0 |
| 36C24025K1002↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 NOVEMBER | Department of Veterans Affairs Department of Veterans Affairs | FY2025 | Nov 1, 2024 – Nov 30, 2024 | $912.0M | $912.0M | 0 |
| 36C24024K1006↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 MARCH | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | Mar 1, 2024 – Mar 31, 2024 | $851.4M | $851.4M | 0 |
| 36C24024K1009↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 JUNE | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | Jun 1, 2024 – Jun 30, 2024 | $838.8M | $838.8M | 0 |
| 36C24025K1004↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 JANUARY | Department of Veterans Affairs Department of Veterans Affairs | FY2025 | Jan 1, 2025 – Jan 31, 2025 | $716.0M | $716.0M | 0 |
| 36C24025K1003↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 DECEMBER | Department of Veterans Affairs Department of Veterans Affairs | FY2025 | Dec 1, 2024 – Dec 31, 2024 | $659.1M | $659.1M | 0 |
| 36C24025K1005↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 FEBRUARY | Department of Veterans Affairs Department of Veterans Affairs | FY2025 | Feb 1, 2025 – Feb 28, 2025 | $633.6M | $633.6M | 0 |
| 36C24024K1008↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 MAY | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | May 1, 2024 – May 31, 2024 | $620.9M | $620.9M | 0 |
| 36C24024K1007↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 APRIL | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | Apr 1, 2024 – Apr 30, 2024 | $610.1M | $610.1M | 0 |
| 36C24024K1004↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 JANUARY | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | Jan 1, 2024 – Jan 31, 2024 | $608.7M | $608.7M | 0 |
| 36C24024K1005↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 FEBRUARY | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | Feb 1, 2024 – Feb 29, 2024 | $567.9M | $567.9M | 0 |
| 36C24024K1001↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 OCTOBER | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | Oct 1, 2023 – Oct 31, 2023 | $559.4M | $559.4M | 0 |
| 36C24024K1002↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 NOVEMBER | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | Nov 1, 2023 – Nov 30, 2023 | $545.4M | $545.4M | 0 |
| 36C24024K1003↗ EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 DECEMBER | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | Dec 1, 2023 – Dec 31, 2023 | $536.9M | $536.9M | 0 |
| 36C26226P1049↗ EMERGENCY DASATINIB, EO 14398 | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | May 26, 2026 – May 25, 2027 | $221K | — | 0 |
| 36C24224P0085↗ PHARMACEUTICALS | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | Oct 17, 2023 – Dec 30, 2023 | $111K | — | 0 |
Observed spellings (1)
Raw recipient names from source records that resolved to this entity.
- MCKESSON CORPORATION
S1RUKWWRYFL6· seen 72×